These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 25549552)
1. Synthesis and molecular modelling studies of 8-arylpyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4-amines as multitarget Ser/Thr kinases inhibitors. Loidreau Y; Deau E; Marchand P; Nourrisson MR; Logé C; Coadou G; Loaëc N; Meijer L; Besson T Eur J Med Chem; 2015 Mar; 92():124-34. PubMed ID: 25549552 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel 7-substituted pyrido[2',3':4,5]furo[3,2-d]pyrimidin-4-amines and their N-aryl analogues and evaluation of their inhibitory activity against Ser/Thr kinases. Deau E; Loidreau Y; Marchand P; Nourrisson MR; Loaëc N; Meijer L; Levacher V; Besson T Bioorg Med Chem Lett; 2013 Dec; 23(24):6784-8. PubMed ID: 24176400 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of N-arylbenzo[b]thieno[3,2-d]pyrimidin-4-amines and their pyrido and pyrazino analogues as Ser/Thr kinase inhibitors. Loidreau Y; Marchand P; Dubouilh-Benard C; Nourrisson MR; Duflos M; Lozach O; Loaëc N; Meijer L; Besson T Eur J Med Chem; 2012 Dec; 58():171-83. PubMed ID: 23124214 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of N-aryl-7-methoxybenzo[b]furo[3,2-d]pyrimidin-4-amines and their N-arylbenzo[b]thieno[3,2-d]pyrimidin-4-amine analogues as dual inhibitors of CLK1 and DYRK1A kinases. Loidreau Y; Marchand P; Dubouilh-Benard C; Nourrisson MR; Duflos M; Loaëc N; Meijer L; Besson T Eur J Med Chem; 2013 Jan; 59():283-95. PubMed ID: 23237976 [TBL] [Abstract][Full Text] [Related]
5. Discovery of novel tricyclic pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4-amine derivatives as VEGFR-2 inhibitors. Abdel Aziz YM; Said MM; El Shihawy HA; Abouzid KA Bioorg Chem; 2015 Jun; 60():1-12. PubMed ID: 25899678 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of substituted (thieno[2,3-d]pyrimidin-4-ylthio)carboxylic acids as inhibitors of human protein kinase CK2. Golub AG; Bdzhola VG; Briukhovetska NV; Balanda AO; Kukharenko OP; Kotey IM; Ostrynska OV; Yarmoluk SM Eur J Med Chem; 2011 Mar; 46(3):870-6. PubMed ID: 21276643 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and optimization of an original V-shaped collection of 4-7-disubstituted pyrido[3,2-d]pyrimidines as CDK5 and DYRK1A inhibitors. Dehbi O; Tikad A; Bourg S; Bonnet P; Lozach O; Meijer L; Aadil M; Akssira M; Guillaumet G; Routier S Eur J Med Chem; 2014 Jun; 80():352-63. PubMed ID: 24793883 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of N-phenylthieno[2,3-d]pyrimidin-4-amines as inhibitors of FGFR1. Gryshchenko AA; Bdzhola VG; Balanda AO; Briukhovetska NV; Kotey IM; Golub AG; Ruban TP; Lukash LL; Yarmoluk SM Bioorg Med Chem; 2015 May; 23(9):2287-93. PubMed ID: 25817240 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and optimization of substituted furo[2,3-d]-pyrimidin-4-amines and 7H-pyrrolo[2,3-d]pyrimidin-4-amines as ACK1 inhibitors. Jiao X; Kopecky DJ; Liu J; Liu J; Jaen JC; Cardozo MG; Sharma R; Walker N; Wesche H; Li S; Farrelly E; Xiao SH; Wang Z; Kayser F Bioorg Med Chem Lett; 2012 Oct; 22(19):6212-7. PubMed ID: 22929232 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of pyrido-thieno-pyrimidines as potent and selective Cdc7 kinase inhibitors. Zhao C; Tovar C; Yin X; Xu Q; Todorov IT; Vassilev LT; Chen L Bioorg Med Chem Lett; 2009 Jan; 19(2):319-23. PubMed ID: 19071019 [TBL] [Abstract][Full Text] [Related]
11. Discovery of novel thieno[2,3-d]pyrimidin-4-yl hydrazone-based inhibitors of Cyclin D1-CDK4: synthesis, biological evaluation, and structure-activity relationships. Horiuchi T; Chiba J; Uoto K; Soga T Bioorg Med Chem Lett; 2009 Jan; 19(2):305-8. PubMed ID: 19091560 [TBL] [Abstract][Full Text] [Related]
12. Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co-crystal structure. Esvan YJ; Zeinyeh W; Boibessot T; Nauton L; Théry V; Knapp S; Chaikuad A; Loaëc N; Meijer L; Anizon F; Giraud F; Moreau P Eur J Med Chem; 2016 Aug; 118():170-7. PubMed ID: 27128181 [TBL] [Abstract][Full Text] [Related]
13. Discovery of Potent Antiproliferative Agents Targeting EGFR Tyrosine Kinase Based on the Pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4-amine Scaffold. Aziz YM; Said MM; El Shihawy HA; Tolba MF; Abouzid KA Chem Pharm Bull (Tokyo); 2015; 63(12):1015-28. PubMed ID: 26633023 [TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel protein kinase CK2 inhibitors on the base of 4-aminothieno[2,3-d]pyrimidines. Ostrynska OV; Balanda AO; Bdzhola VG; Golub AG; Kotey IM; Kukharenko OP; Gryshchenko AA; Briukhovetska NV; Yarmoluk SM Eur J Med Chem; 2016 Jun; 115():148-60. PubMed ID: 27017545 [TBL] [Abstract][Full Text] [Related]
15. Entry into a new class of protein kinase inhibitors by pseudo ring design. Furet P; Caravatti G; Guagnano V; Lang M; Meyer T; Schoepfer J Bioorg Med Chem Lett; 2008 Feb; 18(3):897-900. PubMed ID: 18248988 [TBL] [Abstract][Full Text] [Related]
16. Discovery of novel thieno[2,3-d]pyrimidin-4-yl hydrazone-based inhibitors of cyclin D1-CDK4: synthesis, biological evaluation and structure-activity relationships. Part 2. Horiuchi T; Nagata M; Kitagawa M; Akahane K; Uoto K Bioorg Med Chem; 2009 Dec; 17(23):7850-60. PubMed ID: 19889545 [TBL] [Abstract][Full Text] [Related]
17. Irreversible inhibitors of the epidermal growth factor receptor: thienopyrimidine core with α,β-unsaturated amide side chain. Yang XL; Wang TC; Lin S; Fan HX Arch Pharm (Weinheim); 2014 Aug; 347(8):552-8. PubMed ID: 24917121 [TBL] [Abstract][Full Text] [Related]
18. Discovery of 5-(2-(phenylamino)pyrimidin-4-yl)thiazol-2(3H)-one derivatives as potent Mnk2 inhibitors: synthesis, SAR analysis and biological evaluation. Diab S; Teo T; Kumarasiri M; Li P; Yu M; Lam F; Basnet SK; Sykes MJ; Albrecht H; Milne R; Wang S ChemMedChem; 2014 May; 9(5):962-72. PubMed ID: 24677692 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of novel 7-substituted 3-(4-phenoxyphenyl)thieno[3,2-c]pyridin-4-amines as potent Bruton's tyrosine kinase (BTK) inhibitors. Xin M; Zhao X; Huang W; Jin Q; Wu G; Wang Y; Tang F; Xiang H Bioorg Med Chem; 2015 Oct; 23(19):6250-7. PubMed ID: 26344595 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological evaluation and molecular modelling studies of 4-anilinoquinazoline derivatives as protein kinase inhibitors. Waiker DK; Karthikeyan C; Poongavanam V; Kongsted J; Lozach O; Meijer L; Trivedi P Bioorg Med Chem; 2014 Mar; 22(6):1909-15. PubMed ID: 24530227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]